Cargando…

Quizalofop-p-Ethyl Induces Adipogenesis in 3T3-L1 Adipocytes

Exposure to endocrine disrupting chemicals is an established risk factor for obesity. The most commonly used pesticide active ingredients have never been tested in an adipogenesis assay. We tested for the first time the potential of glyphosate, 2, 4-dichlorophenoxyacetic acid, dicamba, mesotrione, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Biserni, Martina, Mesnage, Robin, Ferro, Raquel, Wozniak, Eva, Xenakis, Theodoros, Mein, Charles A, Antoniou, Michael N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657571/
https://www.ncbi.nlm.nih.gov/pubmed/31086981
http://dx.doi.org/10.1093/toxsci/kfz097
_version_ 1783438815065538560
author Biserni, Martina
Mesnage, Robin
Ferro, Raquel
Wozniak, Eva
Xenakis, Theodoros
Mein, Charles A
Antoniou, Michael N
author_facet Biserni, Martina
Mesnage, Robin
Ferro, Raquel
Wozniak, Eva
Xenakis, Theodoros
Mein, Charles A
Antoniou, Michael N
author_sort Biserni, Martina
collection PubMed
description Exposure to endocrine disrupting chemicals is an established risk factor for obesity. The most commonly used pesticide active ingredients have never been tested in an adipogenesis assay. We tested for the first time the potential of glyphosate, 2, 4-dichlorophenoxyacetic acid, dicamba, mesotrione, isoxaflutole, and quizalofop-p-ethyl (QpE) to induce lipid accumulation in murine 3T3-L1 adipocytes. Only QpE caused a dose-dependent statistically significant triglyceride accumulation from a concentration of 5 up to 100 µM. The QpE commercial formulation Targa Super was 100 times more cytotoxic than QpE alone. Neither the estrogen receptor antagonist ICI 182, 780 nor the glucocorticoid receptor antagonist RU486 was able to block the QpE-induced lipid accumulation. RNAseq analysis of 3T3-L1 adipocytes exposed to QpE suggests that this compound exerts its lipid accumulation effects via a peroxisome proliferator-activated receptor gamma (PPARγ)-mediated pathway, a nuclear receptor whose modulation influences lipid metabolism. QpE was further shown to be active in a PPARγ reporter gene assay at 100 µM, reaching 4% of the maximal response produced by rosiglitazone, which acts as a positive control. This indicates that lipid accumulation induced by QpE is only in part caused by PPARγ activation. The lipid accumulation capability of QpE we observe suggest that this pesticide, whose use is likely to increase in coming years may have a hitherto unsuspected obesogenic property.
format Online
Article
Text
id pubmed-6657571
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-66575712019-08-02 Quizalofop-p-Ethyl Induces Adipogenesis in 3T3-L1 Adipocytes Biserni, Martina Mesnage, Robin Ferro, Raquel Wozniak, Eva Xenakis, Theodoros Mein, Charles A Antoniou, Michael N Toxicol Sci Molecular, Biochemical, and Systems Toxicology Exposure to endocrine disrupting chemicals is an established risk factor for obesity. The most commonly used pesticide active ingredients have never been tested in an adipogenesis assay. We tested for the first time the potential of glyphosate, 2, 4-dichlorophenoxyacetic acid, dicamba, mesotrione, isoxaflutole, and quizalofop-p-ethyl (QpE) to induce lipid accumulation in murine 3T3-L1 adipocytes. Only QpE caused a dose-dependent statistically significant triglyceride accumulation from a concentration of 5 up to 100 µM. The QpE commercial formulation Targa Super was 100 times more cytotoxic than QpE alone. Neither the estrogen receptor antagonist ICI 182, 780 nor the glucocorticoid receptor antagonist RU486 was able to block the QpE-induced lipid accumulation. RNAseq analysis of 3T3-L1 adipocytes exposed to QpE suggests that this compound exerts its lipid accumulation effects via a peroxisome proliferator-activated receptor gamma (PPARγ)-mediated pathway, a nuclear receptor whose modulation influences lipid metabolism. QpE was further shown to be active in a PPARγ reporter gene assay at 100 µM, reaching 4% of the maximal response produced by rosiglitazone, which acts as a positive control. This indicates that lipid accumulation induced by QpE is only in part caused by PPARγ activation. The lipid accumulation capability of QpE we observe suggest that this pesticide, whose use is likely to increase in coming years may have a hitherto unsuspected obesogenic property. Oxford University Press 2019-08 2019-04-17 /pmc/articles/PMC6657571/ /pubmed/31086981 http://dx.doi.org/10.1093/toxsci/kfz097 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the Society of Toxicology http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contactjournals.permissions@oup.com
spellingShingle Molecular, Biochemical, and Systems Toxicology
Biserni, Martina
Mesnage, Robin
Ferro, Raquel
Wozniak, Eva
Xenakis, Theodoros
Mein, Charles A
Antoniou, Michael N
Quizalofop-p-Ethyl Induces Adipogenesis in 3T3-L1 Adipocytes
title Quizalofop-p-Ethyl Induces Adipogenesis in 3T3-L1 Adipocytes
title_full Quizalofop-p-Ethyl Induces Adipogenesis in 3T3-L1 Adipocytes
title_fullStr Quizalofop-p-Ethyl Induces Adipogenesis in 3T3-L1 Adipocytes
title_full_unstemmed Quizalofop-p-Ethyl Induces Adipogenesis in 3T3-L1 Adipocytes
title_short Quizalofop-p-Ethyl Induces Adipogenesis in 3T3-L1 Adipocytes
title_sort quizalofop-p-ethyl induces adipogenesis in 3t3-l1 adipocytes
topic Molecular, Biochemical, and Systems Toxicology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657571/
https://www.ncbi.nlm.nih.gov/pubmed/31086981
http://dx.doi.org/10.1093/toxsci/kfz097
work_keys_str_mv AT bisernimartina quizalofoppethylinducesadipogenesisin3t3l1adipocytes
AT mesnagerobin quizalofoppethylinducesadipogenesisin3t3l1adipocytes
AT ferroraquel quizalofoppethylinducesadipogenesisin3t3l1adipocytes
AT wozniakeva quizalofoppethylinducesadipogenesisin3t3l1adipocytes
AT xenakistheodoros quizalofoppethylinducesadipogenesisin3t3l1adipocytes
AT meincharlesa quizalofoppethylinducesadipogenesisin3t3l1adipocytes
AT antonioumichaeln quizalofoppethylinducesadipogenesisin3t3l1adipocytes